Status:
TERMINATED
Airway Clearance for Pediatric and Adult Cystic Fibrosis Patients Using a Portable Intra-Pulmonary Percussion Device
Lead Sponsor:
University of Florida
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
6-21 years
Phase:
NA
Brief Summary
This is a pilot study where the investigators aim to compare initial use of the standard airway clearance device (SACD), most commonly used being High frequency vest airway clearance system (VEST) wit...
Eligibility Criteria
Inclusion
- Ages 6-21 years
- Cystic fibrosis stable by physician assessment
- Assents to forego additional experimental treatments during the study
- Currently using and familiar with airway clearance therapy for treatment of cystic fibrosis
- Participant (or parent or legal guardian if the participant is a minor) is willing to provide -----Informed Consent
Exclusion
- FEV1 \< 40% predictive
- Pneumothorax
- Hemoptysis
- Coronavirus disease (COVID) 19 diagnosis within last 14 days
- Any condition that, in the opinion of the investigator, would interfere with the study conduct or the safety of the participant
- Additional
Key Trial Info
Start Date :
May 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04743206
Start Date
May 18 2021
End Date
August 1 2021
Last Update
November 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UF Medical Plaza Pulmonary Clinic
Gainesville, Florida, United States, 32610